Description

BSE announces Demat Auction for Settlement No. 833 dated 06/03/2026, listing securities eligible for auction with their respective quantities.

Summary

BSE has published the Demat Auction notice for Settlement No. 833 dated 06/03/2026. The auction lists approximately 80 securities with specified quantities that are subject to demat auction as part of the exchange’s standard settlement process.

Key Points

  • Settlement No. 833 dated 06/03/2026
  • Approximately 80 scrips are listed for demat auction
  • Quantities range from 1 share (e.g., ASHOK LEYLAND, ASIAN PAINTS) to 27,542 shares (ROUTE MOBILE)
  • Notable high-quantity lots include: ROUTE MOBILE (27,542), SOFCOM SYSTEMS (17,625), TRANSGENE BIOTEK (12,213), CHANDRIMA MERCANTILE (9,762), PATEL ENGINEERING (1,000)
  • Covers a wide range of sectors including pharma, energy, finance, infrastructure, and FMCG

Regulatory Changes

No regulatory changes. This is a routine operational notice for demat auction under standard BSE settlement procedures.

Compliance Requirements

  • Participants holding positions in the listed scrips should review their auction obligations
  • Brokers and clearing members must ensure settlement of auctioned quantities as per BSE norms
  • Buyers in the auction must fulfill payment obligations per the settlement schedule

Important Dates

  • Auction Date: 06/03/2026
  • Settlement No.: 833

Impact Assessment

This is a routine demat auction affecting approximately 80 securities across diverse sectors. The impact is limited to specific holders of the listed scrips who failed to deliver securities in the normal settlement cycle. Stocks with large auction quantities (ROUTE MOBILE: 27,542; SOFCOM SYSTEMS: 17,625; TRANSGENE BIOTEK: 12,213) may see minor price discovery effects during the auction. Blue-chip stocks like RELIANCE, INFOSYS, ITC, VEDANTA, and HINDALCO appear with very small quantities (1–101 shares), indicating minimal systemic impact.

Impact Justification

Routine demat auction notice affecting a broad set of securities; relevant to holders of listed stocks but a standard settlement process with no systemic regulatory change.